TriMas Q4 adjusted EPS $0.62, up 10.7% YoY; FY2023 guidance $2.00-$2.20

TRIMAS CORP

2022-FY EPS reported $1.56 revenue$883,830,000

Q4 net sales $203.3M (-2.7% YoY); adjusted diluted EPS $0.62 (+10.7% YoY).
Full year 2022 net sales $883.8M (+3.1%); adjusted diluted EPS $2.12 vs $2.24 in 2021.
2023 outlook: sales +10-15%; adjusted EPS $2.00-$2.20; Q1 adj. EPS $0.24-$0.28.
Acquired Aarts Packaging (closed Q1 2023) and announced Weldmac Manufacturing acquisition.
Returned ~3% yield via buybacks ($36.9M) and dividends; leverage 1.9x; cash $112.1M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

TRIMAS CORP reported fourth quarter ended December 31, 2022 results: revenue $203.3 million, net income $18.8 million, or $0.45 per diluted share, EPS $0.45 per diluted share.

Period: fourth quarter ended December 31, 2022
Revenue: $203.3 million
Net income: $18.8 million, or $0.45 per diluted share
EPS: $0.45 per diluted share
Result: reported results

Exact text from the filing

TriMas reported fourth quarter net sales of $203.3 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

TRIMAS CORP reported full year ended December 31, 2022 results: revenue $883.8 million, net income $66.2 million, or $1.56 per diluted share, EPS $1.56 per diluted share.

Period: full year ended December 31, 2022
Revenue: $883.8 million
Net income: $66.2 million, or $1.56 per diluted share
EPS: $1.56 per diluted share
Result: reported results

Exact text from the filing

For the full year 2022, TriMas reported net sales of $883.8 million

View on SEC.gov

Browse all earnings releases →

TRIMAS CORP filing history →

Source: SEC EDGAR

accession 0000842633-23-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.